Adage Capital Partners Gp, L.L.C. Alnylam Pharmaceuticals, Inc. Transaction History

Adage Capital Partners Gp, L.L.C.

$56.4 Billion
Q2 2025

A detailed history of Adage Capital Partners Gp, L.L.C. transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Adage Capital Partners Gp, L.L.C. holds 84,390 shares of ALNY stock, worth $38.8 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

84,390

Previous 282,184 70.09%

Holding current value

$38.8 Million

Previous $76.2 Million 63.88%

% of portfolio

0.05%

Previous 0.15%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	SELL	$224.32 - $326.09 $44.4 Million - $64.5 Million	-197,794 Reduced 70.09%	84,390 $27.5 Million
Q1 2025 May 15, 2025	BUY	$233.07 - $290.7 $44.1 Million - $55 Million	189,128 Added 203.24%	282,184 $76.2 Million
Q4 2024 Feb 14, 2025	SELL	$232.27 - $300.43 $5.33 Million - $6.89 Million	-22,944 Reduced 19.78%	93,056 $21.9 Million
Q3 2024 Nov 14, 2024	SELL	$233.81 - $287.01 $32.3 Million - $39.6 Million	-138,000 Reduced 54.33%	116,000 $31.9 Million
Q2 2024 Aug 14, 2024	BUY	$143.31 - $247.0 $36.4 Million - $62.7 Million	254,000 New	254,000 $61.7 Million
Q3 2022 Nov 14, 2022	BUY	$138.54 - $232.0 $43.6 Million - $73.1 Million	315,000 Added 185.29%	485,000 $97.1 Million
Q2 2022 Aug 15, 2022	BUY	$120.42 - $169.29 $11.8 Million - $16.5 Million	97,700 Added 135.13%	170,000 $24.8 Million
Q1 2022 May 16, 2022	SELL	$127.18 - $173.91 $7.63 Million - $10.4 Million	-60,000 Reduced 45.35%	72,300 $11.8 Million
Q4 2021 Feb 14, 2022	BUY	$159.56 - $209.29 $21.1 Million - $27.7 Million	132,300 New	132,300 $22.4 Million
Q2 2018 Aug 14, 2018	SELL	$88.31 - $107.8 $21.2 Million - $25.9 Million	-240,000 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$115.92 - $148.54 $5.8 Million - $7.43 Million	-50,000 Reduced 17.24%	240,000 $28.6 Million
Q4 2017 Feb 14, 2018	BUY	$114.49 - $139.98 $33.2 Million - $40.6 Million	290,000	290,000 $36.8 Million

Others Institutions Holding ALNY

# of Institutions

746

Shares Held

115M

Call Options Held

584K

Put Options Held

672K

View Full List

About ALNYLAM PHARMACEUTICALS, INC.

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $56.5B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

More about ALNY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Adage Capital Partners Gp, L.L.C., based on Form 13F filings with the SEC.

News

Stay updated on Adage Capital Partners Gp, L.L.C. with notifications on news.

Account

Adage Capital Partners Gp, L.L.C. Alnylam Pharmaceuticals, Inc. Transaction History